Skip to main content
Log in

Efficacy and Safety of Endoscopic Balloon Dilation for Upper Gastrointestinal Strictures of Crohn’s Disease

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Few articles focused on endoscopic balloon dilation (EBD) in the management of Crohn’s strictures in the upper gastrointestinal (GI) tract.

Aims

The purpose of this study was to evaluate the long-term efficacy and safety of EBD for Crohn’s strictures in the upper GI tract and to determine early predictors of response and surgical intervention.

Methods

All eligible patients who underwent EBD for Crohn’s strictures in the upper GI tract were retrospectively reviewed. The long-term success was defined as the recovery of normal diets without surgical intervention over the follow-up period. In order to seek early predictors, patients who achieved long-term success were compared with those who didn’t.

Results

A total of 67 dilations of upper GI strictures were performed between June 2011 and March 2015 on 24 patients (mean age 25.6 ± 6.7, 20 male) with Crohn’s disease. Technical success was achieved in 62 of 67 dilations (92.5 %) with a complication rate of 3 %. After the median follow-up period of 23.0 months (range 6.2–51.2 months), nine patients underwent surgical intervention, nine patients were still depending on tube feeding; in the meantime, only six (25 %) patients achieved long-term success. Additionally, patients who remained 1 month intervention-free (55.6 vs. 5.9 %, P = 0.015) were more likely to achieve long-term success.

Conclusions

EBD was a safe procedure, but not a potent therapy for Crohn’s upper GI strictures. Meanwhile, 1-month response could serve as an early predictor of the long-term response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Gottlieb C, Alpert S. Regional jejunitis. Am J Roentgenol. 1937;38:881–883.

    Google Scholar 

  2. Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: current management. J Crohns Colitis. 2010;4:28–62.

    Article  CAS  PubMed  Google Scholar 

  3. Lossing A, Langer B, Jeejeebhoy KN. Gastroduodenal Crohn’s disease: diagnosis and selection of treatment. Can J Surg. 1983;26:358–360.

    CAS  PubMed  Google Scholar 

  4. Nugent FW, Roy MA. Duodenal Crohn’s disease: an analysis of 89 cases. Am J Gastroenterol. 1989;84:249–254.

    CAS  PubMed  Google Scholar 

  5. Van Assche G, Geboes K, Rutgeerts P. Medical therapy for Crohn’s disease strictures. Inflamm Bowel Dis. 2004;10:55–60.

    Article  PubMed  Google Scholar 

  6. Rieder F, Fiocchi C. Intestinal fibrosis in IBD-a dynamic, multifactorial process. Nat Rev Gastroenterol Hepatol. 2009;6:228–235.

    Article  CAS  PubMed  Google Scholar 

  7. Fielding JF, Toye DK, Beton DC, Cooke WT. Crohn’s disease of the stomach and duodenum. Gut. 1970;11:1001–1006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Ross TM, Fazio VW, Farmer RG. Long-term results of surgical treatment for Crohn’s disease of the duodenum. Ann Surg. 1983;197:399–406.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Murray JJ, Schoetz DJ Jr, Nugent FW, Coller JA, Veidenheimer MC. Surgical management of Crohn’s disease involving the duodenum. Am J Surg. 1984;147:58–65.

    Article  CAS  PubMed  Google Scholar 

  10. Sunada K, Shinozaki S, Nagayama M, et al. Long-term outcomes in patients with small intestinal strictures secondary to Crohn’s disease after double-balloon endoscopy-assisted balloon dilation. Inflamm Bowel Dis. 2016;22:380–386.

    Article  PubMed  Google Scholar 

  11. Chen M, Shen B. Endoscopic therapy in Crohn’s disease: principle, preparation, and technique. Inflamm Bowel Dis. 2015;21:2222–2240.

    Article  PubMed  Google Scholar 

  12. Hassan C, Zullo A, De Francesco V, et al. Systematic review: endoscopic dilatation in Crohn’s disease. Aliment Pharmacol Ther. 2007;26:1457–1464.

    Article  CAS  PubMed  Google Scholar 

  13. Hirai F, Beppu T, Takatsu N, et al. Long-term outcome of endoscopic balloon dilation for small bowel strictures in patients with Crohn’s disease. Dig Endosc. 2014;26:545–551.

    Article  PubMed  Google Scholar 

  14. Chen M, Shen B. Comparable short- and long-term outcomes of colonoscopic balloon dilation of Crohn’s disease and benign non-Crohn’s disease strictures. Inflamm Bowel Dis. 2014;20:1739–1746.

    Article  PubMed  Google Scholar 

  15. Atreja A, Aggarwal A, Dwivedi S, et al. Safety and efficacy of endoscopic dilation for primary and anastomotic Crohn’s disease strictures. J Crohns Colitis. 2014;8:392–400.

    Article  PubMed  Google Scholar 

  16. Thienpont C, D’Hoore A, Vermeire S, et al. Long-term outcome of endoscopic dilatation in patients with Crohn’s disease is not affected by disease activity or medical therapy. Gut. 2010;59:320–324.

    Article  CAS  PubMed  Google Scholar 

  17. Murthy UK. Repeated hydrostatic balloon dilation in obstructive gastroduodenal Crohn’s disease. Gastrointest Endosc. 1991;37:484–485.

    Article  CAS  PubMed  Google Scholar 

  18. Kelly SM, Hunter JO. Endoscopic balloon dilatation of duodenal strictures in Crohn’s disease. Postgrad Med J. 1995;71:623–624.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Matsui T, Hatakeyama S, Ikeda K, Yao T, Takenaka K, Sakurai T. Long-term outcome of endoscopic balloon dilation in obstructive gastroduodenal Crohn’s disease. Endoscopy. 1997;29:640–645.

    Article  CAS  PubMed  Google Scholar 

  20. Matsui T, Ikeda K, Tsuda S, et al. Long-term outcome of endoscopic balloon dilation in obstructive gastrointestinal Crohn’s disease: a prospective long-term study. Diagn Ther Endosc. 2000;6:67–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Singh VV, Draganov P, Valentine J. Efficacy and safety of endoscopic balloon dilation of symptomatic upper and lower gastrointestinal Crohn’s disease strictures. J Clin Gastroenterol. 2005;39:284–290.

    Article  PubMed  Google Scholar 

  22. Li Y, Stocchi L, Shen B, Liu X, Remzi FH. Salvage surgery after failure of endoscopic balloon dilatation versus surgery first for ileocolonic anastomotic stricture due to recurrent Crohn’s disease. Br J Surg. 2015;102:1418–1425.

    Article  CAS  PubMed  Google Scholar 

  23. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5–36.

    Article  Google Scholar 

  24. Shen B, Lian L, Kiran RP, et al. Efficacy and safety of endoscopic treatment of ileal pouch strictures. Inflamm Bowel Dis. 2011;17:2527–2535.

    Article  PubMed  Google Scholar 

  25. Ko OB, Ye BD, Yang SK, et al. The outcome of fluoroscopically guided balloon dilation of pyloric stricture in Crohn disease. J Vasc Interv Radiol. 2011;22:1153–1158.

    Article  PubMed  Google Scholar 

  26. Zhu W, Li Y, Gong J, et al. Tripterygium wilfordii Hook. f. versus azathioprine for prevention of postoperative recurrence in patients with Crohn’s disease: a randomized clinical trial. Dig Liver Dis. 2015;47:14–19.

    Article  CAS  PubMed  Google Scholar 

  27. Sun J, Shen X, Dong J, et al. Tripterygium wilfordii Hook F as maintenance treatment for Crohn’s disease. Am J Med Sci. 2015;350:345–351.

    Article  PubMed  Google Scholar 

  28. Krishna G, Liu K, Shigemitsu H, Gao M, Raffin TA, Rosen GD. PG490-88, a derivative of triptolide, blocks bleomycin-induced lung fibrosis. Am J Pathol. 2001;158:997–1004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Zhang Z, Qu X, Ni Y, et al. Triptolide protects rat heart against pressure overload-induced cardiac fibrosis. Int J Cardiol. 2013;168:2498–2505.

    Article  PubMed  Google Scholar 

  30. Liu M, Chen J, Huang Y, et al. Triptolide alleviates isoprenaline-induced cardiac remodeling in rats via TGF-β1/Smad3 and p38 MAPK signaling pathway. Pharmazie. 2015;70:244–250.

    CAS  PubMed  Google Scholar 

  31. Chong LW, Hsu YC, Chiu YT, Yang KC, Huang YT. Antifibrotic effects of triptolide on hepatic stellate cells and dimethylnitrosamine-intoxicated rats. Phytother Res. 2011;25:990–999.

    Article  CAS  PubMed  Google Scholar 

  32. Bharadwaj S, Fleshner P, Shen B. Therapeutic armamentarium for stricturing Crohn’s disease: medical versus endoscopic versus surgical approaches. Inflamm Bowel Dis. 2015;21:2194–2213.

    Article  PubMed  Google Scholar 

  33. Alcantara M, Rodriguez R, Potenciano JL, Carrobles JL, Munoz C, Gomez R. Endoscopic and bioptic findings in the upper gastrointestinal tract in patients with Crohn’s disease. Endoscopy. 1993;25:282–286.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Weiming Zhu.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to disclose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guo, F., Huang, Y., Zhu, W. et al. Efficacy and Safety of Endoscopic Balloon Dilation for Upper Gastrointestinal Strictures of Crohn’s Disease. Dig Dis Sci 61, 2977–2985 (2016). https://doi.org/10.1007/s10620-016-4242-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-016-4242-y

Keywords

Navigation